How Could Multi-Cancer Early Detection Tests Revolutionize Cancer Treatment? – CRI
Cancer Research Institute (CRI) shared a post on LinkedIn about a paper by Yuxuan Wang et al. published in Cancer Discovery:
“How could multi-cancer early detection (MCED) tests revolutionize cancer treatment?
At Johns Hopkins Medicine, researchers found that this blood test could detect cancer DNA more than three years before a patient receives a clinical diagnosis.
‘Three years earlier provides time for intervention. The tumors are likely to be much less advanced and more likely to be curable,’ emphasizes lead author Dr. Yuxuan Wang.
Read more in Smithsonian Magazine.”
Title: Detection of Cancers Three Years Prior to Diagnosis Using Plasma Cell-Free DNA
Authors: Yuxuan Wang, Corinne E. Joshu, Samuel D. Curtis, Christopher Douville, Vernon A. Burk, Meng Ru, Maria Popoli, Janine Ptak, Lisa Dobbyn, Natalie Silliman, Josef Coresh, Eric Boerwinkle, Anna Prizment, Chetan Bettegowda, Kenneth W. Kinzler, Nickolas Papadopoulos, Elizabeth A. Platz, Bert Vogelstein
You can read the Full Article on Cancer Discovery.
More posts featuring CRI.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023